RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 3.
Figure 3.

PTPRZ1-MET likely confers unique function. (A) Fusion distribution of the Cancer Genome Atlas subtypes in the sGBM samples. The three ZM-fused sGBM samples consisted of one proneural and two classical subtypes. Due to the small sample size, ZM fusion did not show much association with IDH1 mutation. (B) Expression alteration in ZM-fused sGBMs compared with those without it. The former group showed higher expression of the MET-PIK3CA-AKT1 axis, as well as MDM2 and MDM4. (C) ZM-fused sGBM samples had a significantly shorter overall survival. (D) ZM-fused sGBM samples showed a higher proportion of MET overexpression and EGFR underexpression. (E) EGFR showed no prognostic value in the sGBM samples.

This Article

  1. Genome Res. 24: 1765-1773

Preprint Server